JAK1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.656700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.231900E-02
Normal-vs-Stage2
5.058500E-03
Normal-vs-Stage3
2.971600E-02
Normal-vs-Stage4
1.933180E-01
Stage1-vs-Stage2
2.608200E-01
Stage1-vs-Stage3
9.625400E-01
Stage1-vs-Stage4
6.271900E-02
Stage2-vs-Stage3
3.276000E-01
Stage2-vs-Stage4
2.074800E-01
Stage3-vs-Stage4
3.111700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.417500E-03
Normal-vs-AfricanAmerican
3.836600E-01
Normal-vs-Asian
1.023790E-02
Caucasian-vs-AfricanAmerican
3.015400E-01
Caucasian-vs-Asian
3.419600E-01
AfricanAmerican-vs-Asian
1.115850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.116300E-03
Normal-vs-Female
3.642800E-03
Male-vs-Female
3.181800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.300300E-02
Normal-vs-Age(41-60Yrs)
1.579900E-02
Normal-vs-Age(61-80Yrs)
2.723300E-03
Normal-vs-Age(81-100Yrs)
1.220280E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.216750E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.458000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.619400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.058570E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.678500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.161600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.583800E-03
Normal-vs-Daily Drinker
6.817200E-04
Normal-vs-Weekly Drinker
8.163600E-03
Normal-vs-Occasional Drinker
1.893570E-02
Normal-vs-Social Drinker
1.094240E-02
Non Drinker-vs-Daily Drinker
3.591200E-01
Non Drinker-vs-Weekly Drinker
7.924000E-01
Non Drinker-vs-Occasional Drinker
3.058600E-01
Non Drinker-vs-Social Drinker
4.340800E-01
Daily Drinker-vs-Weekly Drinker
6.072000E-01
Daily Drinker-vs-Occasional Drinker
6.043700E-02
Daily Drinker-vs-Social Drinker
9.584400E-02
Weekly Drinker-vs-Occasional Drinker
2.649400E-01
Weekly Drinker-vs-Social Drinker
3.474400E-01
Occasional Drinker-vs-Social Drinker
8.353600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.138600E-01
Normal-vs-Grade 2
7.482600E-01
Normal-vs-Grade 3
7.936800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.057430E-01
Grade 1-vs-Grade 3
3.177400E-01
Grade 1-vs-Grade 4
7.138600E-01
Grade 2-vs-Grade 3
3.251400E-01
Grade 2-vs-Grade 4
7.482600E-01
Grade 3-vs-Grade 4
7.936800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.085000E-03
Normal-vs-NonDiabetic
1.896070E-03
Diabetic-vs-NonDiabetic
8.952800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.723200E-03
Normal-vs-NoPancreatitis
2.362600E-03
Pancreatitis-vs-NoPancreatitis
5.702800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.039900E-03
Normal-vs-N1
4.524600E-03
N0-vs-N1
2.769800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.941200E-03
Normal-vs-TP53-NonMutant
2.039800E-02
TP53-Mutant-vs-TP53-NonMutant
8.564400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
